| Market Capitalization (Millions $) |
64 |
| Shares
Outstanding (Millions) |
9 |
| Employees |
165 |
| Revenues (TTM) (Millions $) |
21 |
| Net Income (TTM) (Millions $) |
7,952 |
| Cash Flow (TTM) (Millions $) |
-7 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
DarioHealth Corp is a global digital therapeutics company that focuses on providing individuals with chronic conditions access to remote monitoring and management tools. The company offers a mobile platform that allows patients to monitor and manage their health in real-time. Their flagship product, the Dario blood glucose monitoring system, is designed for people with diabetes and enables them to track their blood sugar levels, medication intake, and lifestyle factors.
DarioHealth's platform also includes coaching, education, and support features to empower individuals in self-managing their conditions. By leveraging technology and data analytics, the company aims to improve health outcomes and reduce the burden on healthcare systems. Additionally, DarioHealth offers its digital therapeutics platform to employers and health plans to support their wellness initiatives and lower healthcare costs.
With a user-friendly interface and connectivity to various health devices, DarioHealth provides a convenient and comprehensive solution for individuals with chronic conditions to stay engaged in their healthcare journey. The company operates globally, serving customers in North America, Europe, and Asia-Pacific regions.
Company Address: 322 W. 57th St. #33B New York 10019 NY
Company Phone Number: 4770-4042 Stock Exchange / Ticker: NASDAQ DRIO
|
12.43% 
104.5 %